Reference intervals and decision limits for plasma lipids and lipoproteins: A practical evaluation of current recommendations

References

• Alström T, Gräsbeck R, Hjelm M, Skandsen S. Recommendations concerning the collection of reference values in clinical chemistry and activity report by the Committee on Reference Values of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Scand J Clin Lab Invest 1975; 35(supl. 144)
   Google Scholar
• International federation of clinical chemistry (IFCC) and International committee for standardization in haematology (ICSH). Approved recommendation (1986) on the theory of reference values. Part 1. The concept of reference values. J Clin Chem Clin Biochem 1987; 25: 337–42
   Google Scholar
• International federation of clinical chemistry (IFCC). Approved recommendation (1987) on the theory of reference values. Part 2. Selection of individuals for the production of reference values. J Clin Chem Clin Biochem 1987; 25: 639–44
   Google Scholar
• International federation of clinical chemistry (IFCC). Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values. J Clin Chem Clin Biochem 1988; 26: 593–8
   Google Scholar
• International federation of clinical chemistry (IFCC) and International committee for standardization in haematology (ICSH). Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values Determination of reference limits. J Clin Chem Clin Biochem 1987; 25: 645–56
   Google Scholar
• The committee on reference values of the Scandinavian society for clinical chemistry. Reference values: A short introduction, R Grasbeck, H E. Solberg, L. Viinikka. Nordic Clinical Chemistry Project, Helsinki 1991; 3–7
   Google Scholar
• Lipid Research Clinics Program. The lipid research clinics coronary primary preventions trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351–64
   PubMed Web of Science ®Google Scholar
• Gordon D J., Probstfield J L., Garrison R J., et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American Studies, Circulation 1989; 79: 8–15
   PubMed Web of Science ®Google Scholar
• Carlson L A., Bottiger L E. Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand 1985; 218: 207–111
   PubMed Web of Science ®Google Scholar
• Austin M A. Plasma triglyceride and coronary heart disease. Arteriosclerosis and Thrombosis 1991; 11: 2–14
   PubMed Web of Science ®Google Scholar
• Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M. Lp(a) Lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986; 59: 199–204
   PubMed Web of Science ®Google Scholar
• Mbewu A D., Durrington P N. Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 1990; 85: 1–14
   PubMed Web of Science ®Google Scholar
• Blankenhorn D H., Nessim S A., Johnson R L., Sanmarco M E., Azen S P., Cashin-Hemphill L. Beneficial effects of combined Colestipol-Niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233–40
   PubMed Web of Science ®Google Scholar
• Yamamoto A. Regression of atherosclerosis in humans by lowering serum cholesterol. Atherosclerosis 1991; 89: 1–10
   PubMed Web of Science ®Google Scholar
• Roeschlau P, Bernt E, Gruber W. Enzymatische Bestimmung des Gesamt-Cholesterins im Serum. Z Klin Chem Klin Biochem 1974; 12: 226
   PubMedGoogle Scholar
• Danielsson B, Ekman R, Fex G, et al. Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuse. Scand J Clin Lab Invest 1978; 38: 113–9
   PubMed Web of Science ®Google Scholar
• Friedewald W T., Levy R I., Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Sampson E J., Demers L M., Krieg A F. Faster enzymatic procedure for serum triglycerides. Clin Chem 1975; 21: 1983–5
   PubMed Web of Science ®Google Scholar
• Jauhiainen M, Koskinen P, Ehnholm C, et al. Lipoprotein (a) and coronary heart disease risk: A nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89: 59–67
   PubMed Web of Science ®Google Scholar
• Lanke J, Horsmann V. Construction of tolerance intervals using moderately-sized samples from skewed distributions. 1993, Dept of Statistics, Univ. of Lund. Technical report
   Google Scholar
• Denke M A., Grundy S M. Hypercholesterolemia in elderly persons: Resolving the treatment dilemma. Ann Intern Med 1990; 112: 780–92
   PubMed Web of Science ®Google Scholar
• Berg B, Solberg H E., Nilsson J E., Tryding N. Practical experience in the selection and preparation of reference individuals: empirical testing of the provisional Scandinavian recommendations. Reference values in laboratory medicine, R Gräsbeck, T Alström. John Wiley & Sons The current state of the art, Chichester 1981; 55–64
   Google Scholar
• Steinmetz J, Panek E, Siest G. Personal and familial factors in cholesterolemia: Criteria for selection of a reference population. Clin Chem 1980; 26: 219–26
   Google Scholar
• Tryding N, Hansson P, Tufvesson C, Sjölin T, Sonntag O. Drug effects in clinical chemistry, 6th edn. The National Corporation of Swedish Pharmacies, Stockholm 1992
   Google Scholar
• Stevenson J C., Crook D, Godsland I F. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98: 83–90
   PubMed Web of Science ®Google Scholar
• Matthews K A., Meilahn E, Kuller L H., Kelsey S F., Caggiula A W., Wing R R. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321: 641–6
   PubMed Web of Science ®Google Scholar
• Garber A M., Sox H C., Littenberg B. Screening asymptomatic adults for cardiac risk factors: The serum cholesterol level. Ann Intern Med 1989; 110: 622–39
   PubMed Web of Science ®Google Scholar
• Report of the National Heart. Lung, and Blood Institute (NHLBT) and the National Institutes of Health Office consensus conference on lowering blood cholesterol to prevent heart disease. JAMA 1985; 253: 2080–6
   Google Scholar
• National education programs working group report on the management of patients with hypertension and high blood cholesterol. Ann Intern Med 1991; 114: 224–37
   PubMed Web of Science ®Google Scholar
• Sempos C, Fulwood R, Haines C, et al. The prevalence of high blood cholesterol levels among adults in the United States. JAMA 1989; 262: 45–52
   PubMed Web of Science ®Google Scholar
• Shaikh A H. Patterns of cholesterol distribution in the participants of a screening project. Lab Med 1991; 22: 258–62
   Google Scholar
• Wilson P WF, Christiansen J C., Anderson K M., Kannel W B. Impact of national guidelines for cholesterol risk factor screening. The Framingham offspring study. JAMA 1989; 262: 41–4
   PubMed Web of Science ®Google Scholar
• Kristiansen I S., Eggen A E., Thelle D S. Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while?. B M J 1991; 302: 1119–22
   PubMed Web of Science ®Google Scholar
• National Board of Health and Welfare, Drug Information Committee, Sweden, Treatment of hyperlipidemia. Almqvist och Wiksell, Uppsala 1989, Bulletin No. 3 1989
   Google Scholar
• Zimetbaum P, Frishman W, Aronson M. Lipids, vascular disease, and dementia with advancing age. Arch Intern Med 1991; 151: 240–4
   Google Scholar
• Boyer H, de Gennes J L., Truffert J, Chatellier G, Dairou F, Bruckert E. Lp(a) levels in different types of dyslipidemia in the French population. Atherosclerosis 1990; 85: 61–9
   Google Scholar
• Scanu A M., Lawn R M., Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med 1991; 115: 209–17
   PubMed Web of Science ®Google Scholar
• Genest J, Jenner J L., McNamara J R., et al. Prevalence of Lipoprotein(a) (Lp(a)) excess in coronary artery disease. Am J Cardiol 1991; 67: 1039–45
   PubMed Web of Science ®Google Scholar
• Kostner G M., Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici G B. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981; 38: 51–61
   PubMed Web of Science ®Google Scholar
• Berg K, Rö O C. Lp(a) lipoprotein level and longevity. Ann Génét 1991; 34: 264–9
   PubMedGoogle Scholar